Synthesis of 11-aminoalkoxy substituted benzophenanthridine derivatives as tyrosyl-DNA phosphodiesterase 1 inhibitors and their anticancer activity

Bioorg Chem. 2022 Jun:123:105789. doi: 10.1016/j.bioorg.2022.105789. Epub 2022 Apr 4.

Abstract

Tyrosyl-DNA phosphodiesterase 1 (TDP1) is an enzyme that repairs DNA lesions caused by the trapping of DNA topoisomerase IB (TOP1)-DNA break-associated crosslinks. TDP1 inhibitors have synergistic effect with TOP1 inhibitors in cancer cells and can overcome cancer cell resistance to TOP1 inhibitors. Here, we report the synthesis of 11-aminoalkoxy substituted benzophenanthridine derivatives as selective TDP1 inhibitors and show that six compounds 14, 16, 18, 20, 25 and 27 exhibit high TDP1 inhibition potency. The most potent TDP1 inhibitor 14 (IC50 = 1.7 ± 0.24 μM) induces cellular TDP1cc formation and shows synergistic effect with topotecan in four human cancer cell lines MCF-7, A549, H460 and HepG2.

Keywords: Anticancer; Benzophenanthridine; DNA repair; Topoisomerase; Tyrosyl-DNA phosphodiesterase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzophenanthridines
  • DNA Topoisomerases, Type I / metabolism
  • Humans
  • Phosphoric Diester Hydrolases* / metabolism
  • Structure-Activity Relationship
  • Topoisomerase I Inhibitors* / pharmacology

Substances

  • Benzophenanthridines
  • Topoisomerase I Inhibitors
  • Phosphoric Diester Hydrolases
  • TDP1 protein, human
  • tyrosyl-DNA phosphodiesterase
  • DNA Topoisomerases, Type I